underpinnings of adverse symptoms and its application to develop personalized strategies to prevent or manage symptoms across populations, settings, and the lifespan (National Institute of Nursing Research, 2016) . Biobehavioral nursing research has been foundational to progress in symptom science as it integrates subjective and objective ways of knowing, incorporates a wide range of methods and measures, and offers a unique contribution to the science of compassion and caring in the symptom experience and approach to symptom management.
The National Institutes of Health Symptom Science Model provides a general framework of the steps involved in knowledge generation and application of symptom science in clinical practice (Cashion & Grady, 2015) . Symptom science from a biobehavioral nursing research perspective is focused on knowledge generation that will answer specific questions related to characterizing symptoms based on patient-specific contextual factors (age, sex, race, ethnicity; by disease/ disease severity or treatments, etc.); identifying symptom phenotypes based on symptom characteristics (single symptom/multiple symptoms, severity, interference, frequency, timing, duration); identifying symptom biomarkers; predicting symptom trajectories; identifying biobehavioral mechanisms of symptom resolution and persistence; and developing mechanistic interventions to prevent or manage symptoms (National Institute of Nursing Research, 2016) .
At no other time in history has the need for interand intraprofessional collaborations been greater in biobehavioral symptom science, with international migration, genetic admixture, and cultural evolution adding complexity to how nurses assess symptoms, study symptoms across populations, and implement approaches to symptom management with patients and families. In addition, the integration of omics in symptom sciencethe collective technologies that are used to measure various types of molecules in humans (i.e., genomics, proteomics, transcriptomics, and metabolomics)-requires an interdisciplinary team-based approach (Hickey et al., 2018) . Successful implementation of omics-based symptom science involves clinicians, basic scientists, statisticians, and bioinformaticians, who must all have a firm understanding of the goals of the research study, be united with the common goal, and have a commitment to ongoing communication and collaboration. With wider implementation of omics within clinical settings for screening and disease diagnosis, clinical nurses need to understand the limitations of these technologies and moral and ethical issues that can arise when they are used (National Academies of Sciences, Engineering, and Medicine, 2018).
However, barriers exist for consolidating inter-and intraprofessional collaborations focused on biobehavioral symptom science, including perceptions about the domains of nursing research, issues of patient privacy, and data sharing. These issues will be examined along with potential solutions that can be used to strengthen and forge new collaborations for the future.
Barriers to Collaborative Symptom Science
Nursing's metaparadigm focused on the person, nurse, health, and environment has been used to delineate the domains of nursing research, with a focus of research outside the scope of these concepts being viewed as nonnursing research (Fawcett, Watson, Neuman, Walker, & Fitzpatrick, 2001 ). However, the biopsychosocial domains of the person are an intrinsic aspect of the metaparadigm that adds depth to the understanding of the person's health and well-being (Masters, 2015) . Related to knowledge discovery and application in symptom science, Carper's (1978) patterns of knowing provide a framework for understanding nursing's epistemological roots as empirical, personal, ethical, aesthetic, and sociopolitical knowing (White, 1995) or emancipatory knowing (Chinn & Kramer, 2011) .
The application of Carper's patterns of knowing in symptom science reflects nursing's value of both the subjective report of the symptom experience and its meaning, as well as the objective biological underpinnings in the development and persistence of symptoms (Sakamoto, 2018) . Symptoms are influenced by multiple factor domains, including personal, behavioral, environmental, social contextual, economic (access to health care), and geographic region. The relationships among these factors and the symptom experience have been articulated in several theoretical models of symptom science (Lenz, Pugh, Milligan, Gift, & Suppe, 1997) and symptom management (Brant, Beck, & Miaskowski, 2009 ; The University of California, San Francisco School of Nursing Symptom Management Faculty Group, 1994) . Thus, symptom science is relevant across nursing specialties, professional associations, and organizations (Figure 1 ). Broadening the perspective of how nursing can contribute to symptom science and vice versa can generate greater diversity in discipline-specific views and experiences with symptoms and symptom management that will benefit the field.
Patient privacy is another significant issue that can be a barrier to inter-and intraprofessional collaboration for advancing biobehavioral symptom science. The risk for violating patient privacy can be decreased with stronger deidentification standards and safer data platforms. These safeguards were integrated into the National Institutes of Health's "All of Us" Research Initiative and are available for other collaborative projects to minimize risks (https://www.joinallofus.org/en/ privacy-safeguards).
Data sharing can be another significant barrier and many aspects should be considered, including development and use of data standards and common data models, and providing secure data platforms (Peterson & Rockhold, 2018) . To facilitate the use of standard symptom measures across studies, the National Institute of Nursing Research P20 and P30 Center Directors have published recommendations for common data elements in symptom science (Redeker et al., 2015) .
The use of common data elements provides a way to examine symptoms across study populations and settings and can maximize data usability. Secure data platforms that house de-identified data are becoming more widely available; however, a different approach is to link investigators who have their own dataset through the Omics Nursing Science and Education Network website recently released by the National Institutes of Nursing Research. Through this approach, data sharing can occur between investigators through a collaborative partnership. Other barriers to collaboration involve organizing and maintaining the team over the duration of the work, processes that are described below. Figure 1 . Symptom science as a common component of practice across nursing associations. General or regional nursing associations are aligned with generalist nursing education, research, and practice, while population-, condition-, or setting-specific associations provide more in-depth knowledge for nurses who are focused on a particular area of care. Each type of association has an overlapping mission to support nurses in their role of improving health and well-being, of which symptom science is a major component. The ways of knowing are fundamental to knowledge generation and application of symptom science.
Looking Within: Team Science and Networking
Similar to other areas of science in which teams have evolved to tackle complex scientific problems, the need to navigate collaborations across disciplines and organizational boundaries has become an important issue in symptom science. As a natural progression of expanding upon a program of research, investigators often seek to verify their findings in populations within different institutions or geographical regions, or with diverse characteristics. However, the additional value of building a productive interprofessional team comes with additional challenges of managing tasks and delegation, communication and follow-up, working through differences in epistemologic and methodologic viewpoints, as well as ensuring equitable recognition of research contributions (Vogel et al., 2013) . To facilitate the successful navigation of these challenges, the National Cancer Institute supports an online Team Science Toolkit that houses a multitude of resources on the science of team science, including forming, leading, and managing teams; engaging translational and community partnerships; and developing training, education, and evaluation tools for promoting team science.
Specialty associations and organizations, such as the American Heart Association, have an interdisciplinary membership that can be leveraged by forming task forces and work groups that are composed of members who represent disciplinary diversity. The interactions among team members can be enhanced by developing ground rules for ensuring adequate representation by each discipline, equitable means of selecting chairs and other leadership positions, as well as delegation of work and follow-through. Associations that have a membership composed of one discipline, such as nursing, can leverage intradisciplinary collaborations by forming a task force or working group focused on specific symptoms, populations, or questions, and by including members with practice-focused and research-focused expertise (such as DNP or PhD collaborations). The infrastructure for advancing symptom science research can be enhanced through collaborations with other disciplinespecific associations or affiliates. For example, the American Academy of Nursing works with a number of external interdisciplinary constituents in their mission to develop, support, and lead policy initiatives that can help to improve the health of individuals and families (including symptom management), access to health care, and efforts to enhance the impact of the nursing workforce across the nation. These efforts cannot move forward easily when done in isolation; thus, capitalizing on the network of affiliations across nursing associations and organizations can lend a powerful voice that can move the profession forward.
Potential Solutions to Augment Inter-and Intraprofessional Collaborations
Nursing organizations can develop collaborations with other affiliate organizations and provide opportunities for advanced training on biobehavioral approaches in symptom science. The collaborations may have a common goal, such as the clinical practice guidelines developed for improving the care of the patient with multiple sclerosis by the American Association of Neuroscience Nurses, American Association of Rehabilitation Nurses, and International Organization of Multiple Sclerosis Nurses (2011). Another organization, the International Society of Nurses in Genetics, provides an ongoing webinar series with invited expert speakers from a range of different disciplines who present content of interest for the membership. In 2017, the National Human Genome Research Institute launched the "Method for Introducing a New Competency: Genomics" website to provide resources for nurse leaders across all levels of practice and administration to guide education and planning of genomics on healthcare systems and policies. These resources could be highlighted by nursing associations or organization for practice improvement, with descriptions of demonstration projects by members or funding opportunities to develop an interprofessional implementation project.
Another strategy that nursing organizations can use to facilitate inter-and intraprofessional collaborations is by developing research, education, and practice activities focused on symptom science of chronic disease. Symptom science is particularly relevant to patients with multiple chronic conditions, and these partnerships can advance how researchers and clinicians understand and manage co-occurring symptoms. In the United States alone, chronic disease affects approximately 133 million Americans, representing more than 40% of the total U.S. population, and accounts for 75% of all healthcare costs (Centers for Disease Control and Prevention, 2013; Ward, 2017) . People living with chronic conditions are not only more likely to have multiple comorbidities but also suffer with common overlapping chronic symptoms. This is an area in which professional associations and organizations can help to build collaborations to strengthen their membership's knowledge and skills for managing common comorbidities (i.e., obesity, diabetes, heart disease, stroke) and symptoms that cross these conditions, and develop innovative strategies for symptom management.
Data sharing and research dissemination across research, education, and practice teams could be another avenue for increasing inter-and intraprofessional collaborations focused on biobehavioral symptom science. Involving interdisciplinary organizations could increase the potential discovery of unique and overlapping symptom trajectories and biological factors. This pursuit can take on multiple forms, from providing specific funding strategies based on inter-and intraprofessional collaborative teams, to disseminating research findings of relevance from other associations through social media. To demonstrate how a program of symptom science research can lead to intra-and intraprofessional collaborations, the following exemplar is presented.
An Exemplar of Building Inter-and Intraprofessional Collaborations in Biobehavioral Symptom Science Research
Nursing associations and organizations play a crucial role in funding new nurse scientists in their development and program of research, including the program of research described herein. The initial study was a dissertation carried out with funding from nursing foundations, including the Association of Spinal Cord Injury Nurses, Emergency Room Nurses Association, and Sigma Theta Tau International, to examine how inflammatory biomarkers influenced acute low back pain recovery or persistence. The dissertation work set the stage for gathering a team composed of nurse scientists and nurse practitioners who were interested in identifying why some people had spontaneous relief of pain while other people did not respond to standard treatment. Our team's interest also developed in identifying biological markers that could predict who would develop chronic pain so that healthcare providers could work with the patient and family to reduce the risk of a chronic pain trajectory with earlier interventions. Due to the prevalence of chronic low back pain and the high associated costs of this condition, this program of research was of interest to several nursing foundations, and they helped to support an interprofessional team of scientists to pursue answering these questions.
From 2013 to 2016, our team conducted a descriptive, exploratory study funded by the National Institute of Nursing Research (R01NR013932). The study included 220 individuals who had an acute onset of low back pain, and a battery of questionnaires was collected on person-specific and psychological factors, quantitative sensory testing, and peripheral blood samples to quantify gene expression every 6 weeks until the patient had resolution of pain or until the end of the study at 6 months.
The remaining discussion about this exemplar is guided by Carper's (1978) ways of knowing to demonstrate how this program of research aligns with nursing's epistemological lens. Using empirical ways of knowing, some important findings about social determinants of health were identified from this sample. For instance, the group of patients who developed chronic pain (n = 42) over 6 months were older compared to the group whose pain resolved by 6 weeks (n = 42; 38.5 ± 1.48 vs. 29.02 ± 1.52 years; p = .000); had a higher body mass index (31.0 ± 1.24 vs. 27.5 ± 1.02; p = .03); had more Black/African Americans (64.3% vs. 16.7%), less Asian (2.4% vs. 19%), and less Caucasian (26.2% vs. 59.5%) participants (p = .000); had lower rates of full-time or part-time employment (66.7% vs. 95.2%; p = .000); had less college education (50% vs. 95.2%; p = .000); and had more current smokers (59.5% vs. 19%; p = .000). Another point of interest identified was the difference in pain severity and interference (Figure 2 ) as well as somatosensory testing between groups at the onset of pain, with the chronic pain group having lower cold pain threshold at the area of their back and a remote site (back area: 21.82 ± 1.13 vs. 16.71 ± 1.56; p = .01; remote site: 19.27 ± 1.25 vs. 16.58 ± 1.51; p = .012), and lower pressure pain threshold at a remote site (199.31 ± 17.39 vs. 249.44 ± 16.85; p = .04). These findings suggest that at the onset of pain, participants who developed chronic pain already had signs of increased pain sensitization. Our team also collected gene expression profiles at baseline and at each follow-up time point to identify differential expression between groups. Although our preliminary results were promising, we were extremely careful about publishing the results because we wanted to ensure that we could replicate the findings. In doing so, our team expanded to encompass other investigators interested in studying the transition to chronic pain in other populations, including fracture pain, temporomandibular joint disorders, and cancer pain. In addition, to begin the development of targeted and mechanistic interventions, we began to collaborate with experts in systems biology to develop greater precision and different viewpoints in using peripheral blood for biomarker discovery.
In addition to empirical and sociopolitical ways of knowing, our team used ethical ways of knowing (Carper, 1978) through thoughtful discussion on the timing and verification required to confidently publish our data on the gene expression profiles. During a period in which we were about to publish the results, several laboratory-developed genetic tests started to become available and were being used to determine whether a patient would be a good candidate for surgery or other treatments, without strong evidence to back up the claims on the strength of the prediction. Especially concerning was that the social determinants identified in our study sample made this group especially vulnerable to the use of genetic testing to limit treatment options; thus, we turned to our professional organization as a collaborator in developing a policy brief on this subject (Starkweather et al., 2018) .
Aesthetic ways of knowing refer to the art of nursing practice (Carper, 1978) , and we have applied aesthetics to generate more information about the pain experience from the patient's perspective. Understanding patient preferences about the options for instrumental, emotional, and social support that would be most beneficial in helping them to manage pain has informed the design of our team's interventions. In turn, our team developed several novel interventions for managing acute and chronic low back pain that we are presently testing to determine whether they are acceptable, reasonable, and impactful in reducing pain and the number of patients who transition to a chronic pain trajectory. Potential collaborations exist with nursing associations and organizations to make these interventions available to the association's members and patients if they are shown to be effective.
The findings from our initial analysis identified several social determinants of the transition from acute to chronic low back pain that are modifiable, such as increasing opportunities for education and employment, decreasing body mass index, and encouraging smoking cessation. These social determinants of health have been central to our team's evolution in emancipatory knowing (Chinn & Kramer, 2011) and how we can use the knowledge generated and interventions developed to make the interventions more understandable, accessible, and relevant to the patients who need it most. Working with community collaborators and social service planners, we are currently developing strategies to assess and evaluate how symptom science and symptom management interventions can be connected with a wider array of support mechanisms, such as education, work placement, and general wellness programs to address the social determinants of health in people with (or at risk for) chronic pain. Another avenue for applying emancipatory ways of knowing is through advocating for insurance carriers to cover evidence-based nonpharmacological interventions for patients with acute and chronic pain, such as massage, acupuncture, and yoga (Tick et al., 2018) . Provider networks who may offer free services to patients without insurance would help to fill the gaps in care that exist. Although these activities often are not viewed as part of the program of research, they can be the most impactful for improving human health, a goal that everyone can agree on.
Conclusions
Biobehavioral symptom science provides a common ground among nursing specialties. Nursing associations and organizations can play an integral role in building inter-and intraprofessional collaborations to advance biobehavioral symptom science and move beyond the challenges of going at it alone. Identifying solutions to the barriers of patient privacy and data sharing can help to augment greater collaborative opportunities for data collection and usage. In addition, principles of team science help to clarify the mission and goals of the project; manage tasks and delegation; and promote accountability. Nursing associations and organizations can lead these efforts by supporting cross-organizational symptom science projects that meet the needs of the members, highlighting symptom science tools in conferences and webinars, and gearing research funding toward studying biobehavioral symptom science in populations with chronic comorbid conditions. These strategies could strengthen the preparation of nurse scientists and other healthcare and scientific disciplines focused on symptom science and accelerate discovery and innovation in nursing science and symptom management.
